CBK(CBK)
CBK
No analyst ratings available
No analyst price targets available for CBK
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $95M | $102M |
| Low | $95M | $102M |
| High | $95M | $102M |
| EBITDA Avg | $35M | $37M |
| Low | $35M | $37M |
| High | $35M | $37M |
| EBIT Avg | $36M | $38M |
| Low | $36M | $38M |
| High | $36M | $38M |
| Net Income Avg | $41M | $44M |
| Low | $41M | $44M |
| High | $41M | $44M |
| EPS Avg | $2.93 | $3.15 |
| Low | $2.93 | $3.15 |
| High | $2.93 | $3.15 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $23M | $24M | $25M | $24M | $25M | $26M | $27M |
| Low | $23M | $24M | $25M | $24M | $25M | $26M | $27M |
| High | $23M | $24M | $25M | $24M | $25M | $26M | $27M |
| EBITDA Avg | $9M | $9M | $9M | $9M | $9M | $10M | $10M |
| Low | $9M | $9M | $9M | $9M | $9M | $10M | $10M |
| High | $9M | $9M | $9M | $9M | $9M | $10M | $10M |
| EBIT Avg | $9M | $9M | $9M | $9M | $9M | $10M | $10M |
| Low | $9M | $9M | $9M | $9M | $9M | $10M | $10M |
| High | $9M | $9M | $9M | $9M | $9M | $10M | $10M |
| Net Income Avg | $10M | $10M | $10M | $10M | $11M | $11M | $12M |
| Low | $10M | $10M | $10M | $10M | $11M | $11M | $12M |
| High | $10M | $10M | $10M | $10M | $11M | $11M | $12M |
| EPS Avg | $0.70 | $0.74 | $0.76 | $0.74 | $0.77 | $0.81 | $0.84 |
| Low | $0.70 | $0.74 | $0.76 | $0.74 | $0.77 | $0.81 | $0.84 |
| High | $0.70 | $0.74 | $0.76 | $0.74 | $0.77 | $0.81 | $0.84 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |